European biotech just enjoyed its most abundant quarter in nearly two years in a tentative sign of a renaissance in the sector. There were 46 deals in Q1 2023, the second biggest year for deals in the region on Mergermarket...more
Private equity (PE) deal activity shrinks as buyer and vendor pricing expectations widen and rising interest rates drive significant tightening in acquisition finance markets -
PE managers endured a testing year in 2022 as...more
M&A activity in Western Europe surged in Q3 on the back of strong PE interest and low UK stock prices -
Dealmaking in Western Europe reached a post-crisis record in the third quarter of the year as dealmaker confidence...more
11/9/2021
/ Acquisitions ,
Bids ,
Buyouts ,
Capital Markets ,
Debt Market ,
EU ,
Global Dealmaking ,
Investors ,
Mergers ,
Private Equity ,
UK
After four quarters in a row of exceptionally high PE activity, Q3 2021 has continued the trend, recording the highest value and volume of any third quarter on record -
The summer months of July and August typically mean...more